Despite the sharp rise in broader U.S. equity markets in 2023, Teladoc Health (TDOC) shares have sagged and are down more than 7% for the year. The stock is now hovering near its 52-week lows, extending its dismal performance of the last couple of years. TDOC peaked at around $295 in February 2021, and has been sliding ever since – including a 74% fall in 2022.
